Muna Therapeutics is a groundbreaking brand that specializes in discovering and developing therapies to combat devastating neurodegenerative diseases such as Alzheimer's, Parkinson's, and Frontotemporal Dementia. With a focus on preserving cognition and brain functions while enhancing resilience to these diseases, Muna Therapeutics aims to improve the quality of life for millions of patients worldwide. Their team of experts integrates scientific insights from human genetics, bioinformatic analyses, and human cell biology to uncover innovative ways to repair neuronal function, resolve chronic neuroinflammation, and restore neuroprotection.

Through their small molecule drug discovery engine, which combines target structural approaches, AI-driven computational chemistry, and cell-based screening, they are advancing first-in-class programs to restore neuron function and resolve neuroinflammation in patients. Driven by a deep sense of purpose, Muna Therapeutics is dedicated to addressing the tremendous unmet medical need for effective treatments for neurodegenerative diseases. Their commitment to breakthrough science and patient-centered innovation sets them apart in their quest to make a meaningful impact in the field